Psoriasis is a chronic, inflammatory, multisystem disease that affects millions of people globally, presenting significant challenges to skin health and overall quality of life [3, 4]. Because the condition is long-lasting and highly variable in its clinical presentation, effective management requires a personalized approach based on clear treatment goals [3]. Dermatologists utilize a wide spectrum of options ranging from localized skin applications to advanced systemic therapies [3, 4].
Understanding Topical and Alternative Approaches
For individuals with localized or mild disease, treatment typically begins with topical agents aimed at reducing inflammation and slowing skin cell turnover [4]. Dermatologists carefully evaluate patients to balance the benefits and potential risks of these topical therapies [4]. In addition to conventional prescription creams, integrative dermatology explores lifestyle and dietary modifications. Changes in diet, body composition, sleep, exercise, and stress management do not replace medical treatment, but they can integrate with conventional care to help address underlying inflammatory factors and manage serious health comorbidities [2].
Systemic Therapies and Biologic Medications
When psoriasis is moderate to severe, topical treatments alone may not be sufficient, prompting the use of systemic therapies. Established systemic options include traditional medications as well as modern biologic drugs administered via subcutaneous, intramuscular, or intravenous routes [1, 3, 8]. Biologics target specific components of the immune system and include tumor necrosis factor (TNF) inhibitors, interleukin (IL)-17 inhibitors, ustekinumab, and IL-23 inhibitors [5]. These advanced therapies can help patients achieve clear skin and a meaningful improvement in their daily well-being, though they require careful medical supervision and baseline screening [3, 5, 6].
Managing Comorbidities and Arthritis
Psoriasis is not confined to the skin; it is a systemic condition linked to a higher risk of cardiovascular diseases and other complications [3]. Notably, approximately one out of five to one-third of psoriasis patients eventually develop psoriatic arthritis, a progressive inflammatory joint disease [3, 7]. Dermatologists play a critical role in recognizing early joint symptoms so that appropriate immunosuppressive or biologic management can be initiated to help prevent long-term physical disability [7].
Personalized Care and Clinical Guidelines
Because every patient experiences psoriasis differently—ranging from mild patches to severe systemic involvement—treatment algorithms must be personalized based on clinical trials, safety profiles, and individual health factors such as existing comorbidities or age [3, 5, 6]. Adhering to established guidelines helps physicians choose the optimum level of care, ensuring safe integration of therapies whether a patient requires simple topical management or complex biologic infusions [1, 3, 8].
Sources
- [1] Practical considerations in future psoriasis therapies. PubMed
- [2] Integrative dermatology for psoriasis: facts and controversies. PubMed
- [3] Psoriasis--new insights into pathogenesis and treatment. PubMed
- [4] Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. PubMed
- [5] Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review. PubMed
- [6] A Practical Guide to Using Biologics in Pediatric Dermatology. PubMed
- [7] Psoriatic arthritis for the dermatologist. PubMed
- [8] 2023 guidelines on the management of psoriasis by the Dermatological Society of Singapore. PubMed